The global CRO Cromsource has opened a new office in Research Triangle Park – home to many current and potential clients – after growing more than 150% over the two years, says COO.
Almac Group’s Diagnostics Business Unit has opened a companion diagnostic development facility, giving the company a US base to support further growth.
Anti-infectives firm Xellia has moved its North American HQ to the lyophilisation plant in Raleigh, North Carolina that it bought from Fresenius Kabi last July.
Beginning Sept. 30, Massachusetts-based CRO (contract research organization) Parexel will lay off as many as 125 of the 450 employees it brought on from GlaxoSmithKline (GSK) in North Carolina late last year, according to a North Carolina WARN report...
The world’s second-largest central lab services company is now operational, with Quintiles and Quest Diagnostics calling their new creation Q2 Solutions.
Tokyo-based CMIC Holdings Co., Innovation Network Corporation of Japan (INCJ), and JSR have agreed to acquire KBI Biopharma, a contract development and manufacturing organization with facilities in Durham and Research Triangle Park, North Carolina and...
The US Biomedical Advanced Research and Development Authority (BARDA) has awarded Novan $7.8 million to aid the development of what the company hopes will be the first FDA-approved drug with a burn healing indication.
Quintiles today announced it will expand its reach into the world of oncology, medical device and diagnostic trials with the acquisition of CRO Novella Clinical.
Catalent has upgraded its North Carolina, US, sterile development and analytics plant to increase its aseptic fill-finish activities four-fold in a bid to boost its integrated biologics offering.
Tokyo, Japan-based digital imaging specialist, Fujifilm, has agreed a deal to buy US drug giant Merck and Co's BioManufacturing Network, including two biotech manufacturing plants.
GlaxoSmithKline (GSK) has confirmed that job cuts in its neurosciences group will affect less than 50 people, but half those cuts are coming from the company's US headquarters in North Carolina.
Synteract is to hire up to 30 additional staff by the end of 2011 to work at its recently expanded site in Research Triangle Park (RTP), North Carolina, US.
Contract research organisation (CRO) Quintiles Transnational has boosted its UK marketing teams through a deal with Nycomed but is planning cutbacks at US operations in RTP.
Eisai has opened a $100m (€81m), 65,000 sq ft commercial manufacturing and drug development site for intravenous treatments in Research Triangle Park (RTP), North Carolina, US.
Pfizer will close six R&D facilities in the US and the UK, reducing its global capacity by over a third following completion of its acquisition of Wyeth.
Massachusetts Biotechnology Council’s (MBC) 2015 strategic plan has outlined the difficulties the state faces in attracting biomanufacturing and called for increased focus on R&D.
Canada’s Patheon put in another quarter of robust revenues growth in its third quarter, which coupled with cost-reduction measures helped the firm trim its net loss to $14.7m, down 75 per cent on a year ago.
Contract research and production specialist Patheon is to promote
BSP Pharmaceuticals' cytotoxic development and manufacturing
services as part of a marketing agreement that the two firms have
signed.
Japan's fourth-largest pharmaceutical company, Eisai, has announced
plans for a new pharmaceutical production and formulation research
and development facility in North Carolina in anticipation of its
parenteral and intravenous...
